Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I would argue that its more the willingness of the Drs to prescribe opiods for a broken nail and people unwilling to accept discomfort in their lives than the dea's fault. Dea is reacting after the problem already exist like most LE situations.
I have 3 bulged disc, a torn ligament in my low back from my time in the military. I have good days and bad days. My Dr has offered me opiods to deal with the bad days and I refuse. Pain is a sign to stop what you're doing and people refuse to listen to it.
Through carefully managing and listening to my body I plan to compete in my first powerlifting competition this year. Almost at my 500 lb squat and deadlift.
And that why I avoid options. It hurts my head and I don't like playing with money I don't have.
Wife had to bail to. She wasn't feeling to great and our friend she was going with had to take their kid to the hospital the night before.
Friend worked the show and said they didn't sound to good. Don't think he's as big of a fan though.
Hey now. I'm 32 & love def leopard
Lol did same then bought back over 4 :'( wont make that mistake twice.
Wife is going to the concert. Was hoping to work it but not going to happen now..
I wonder if Oleptro is the drug they partnered with Teva.. Mifht be why it was never announced.
Anyone know what short interest is at and when do they have to cover by?
Don't see ipci on last one
How much more bleeding do we got
I think he likes to make a lot of stuff up and pretend to be an insider. Seems like he's pumping.
Wonder if this is the hold up for the rest of the generics?
Sounds like they only have to do the test on the 40mg to get approval for all?
Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that the United States Food and Drug Administration ("FDA") has indicated that the Company's tentatively-approved strengths of its generic Focalin XR® (dexmethylphenidate hydrochloride extended-release) capsules (the "Product") will have to meet newly-imposed conditions for bioequivalence prior to receiving final approval. The strengths affected are 5 mg, 10 mg, 20 mg and 40 mg. The already-approved 15 mg and 30 mg strengths now in the market are not affected.
The FDA, in November 2013, had previously granted the Company tentative approvals for the 5 mg, 10 mg, 20 mg, and 40 mg strengths of its generic Focalin XR®. The Company is now required by the FDA to demonstrate bioequivalence with Focalin XR®, under the new bioequivalence criteria, for the 40 mg strength as a basis for the approval of each of the affected strengths.
The Company, together with its United States commercialization partner, Par Pharmaceutical, Inc., intends to review and vigorously pursue all reasonable courses of action towards achieving final approval for each of the affected strengths. There can be no assurance that the affected strengths of the Product will be granted final FDA approval or sold commercially.
No shares traded in almost am hour... News?
The news didn't do much for the stock price.
I hear you bud I made a mistake and held to long during first approval and then bought back in at wrong time too. I want some real news here and hopefully I don't make the same mistake again.
To hell with that.
Lets get an approval and hit double digits.
I stopped listening to him
Do we know of any other drugs that skipped phase 3 & Tim to approvals?
Was kind of hoping to have a series of small green days till end of week... Doesn't look like it'll happen...
I have a feeling its going to come down to dollars and cents like everything else.
I don't think DR's would matter that much. At least here in Canada its what the pharmacy would stock. My dr would prescribe something and when I went to the pharmacy it would be whatever brand they had.
Lets bring on the short squeeze.
Intellipharmaceutics Announces Agreement to Acquire Real Property that Houses its Manufacturing, R&D and Office Facilities in Toronto, Ontario and Status of 5mg Strength of its Generic Focalin XR(R)
TORONTO, May 25, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I)("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that it has agreed to purchase the land and building from which it conducts its operations at 30 Worcester Road, Toronto, Ontario (the "operating property") as well as the land and building of the adjoining property at 22 Worcester Road (the "adjoining property") for a combined purchase price of Cdn. $4,700,000. The operating property has been occupied by the Company since 2004 pursuant to a lease, and is approximately 25,000 sq. ft. The adjoining property includes a building of approximately 40,000 sq. ft. that is not currently occupied by the Company. The adjoining property is expected to provide the Company with space that will permit expansion of the Company's operations. There can be no assurance that the purchase transaction will be completed.
The Company's operating property has been its main site for over 10 years and comprises its management, R&D, manufacturing, quality control and analytical testing components. The United States Food and Drug Administration ("FDA") and Health Canada had previously granted "acceptable" classification to those aspects of the operating facility that permit the Company to be in a position to receive final approvals for certain drug applications and to permit manufacturing, testing, release and storage of drug products intended for commercial sales in the United States and Canada after any such approvals. No assurance can be given as to whether or when the FDA or Health Canada will approve any Intellipharmaceutics application for its product candidates, that its facility will continue to satisfy the requirements of the FDA or Health Canada, or that any of its product candidates will be successfully commercialized.
The purchase transaction is subject to various closing conditions, including the Company obtaining financing that is satisfactory to the Company, and the property owner obtaining a municipal severance approval necessary for the transfer of the properties. Prior to entering into the agreement to acquire the properties, in order to ensure continuity of use of its operating property in the event the acquisition was not consummated, the Company also recently exercised its right to renew its lease of the operating property for a term of five years to November 2020, beyond the expiry of the current term ending November 30, 2015.
"I am very pleased we have taken these steps to secure the continued use of our existing operating facilities. In addition, if the acquisition transaction proceeds, the acquisition of the adjoining property will accommodate our anticipated growth requirements given the numerous product candidates of the Company pending regulatory approval," stated Dr. Isa Odidi, the Company's Chair and CEO.
Separately, the Company advised that a final FDA approval has not yet been issued to the Company for the 5 mg strength of its generic dexmethylphenidate generic of Focalin XR®. Although the Company has not received any indication from the FDA of a deficiency in its application for approval of the 5 mg strength, the Company has no further information as to when or if such final approval will be granted by the FDA.
, .
Expanding to start a manufacturing facility? Was hoping for an approval on the 5mg
I own both probably 50/50 equal so I follow both... 8% as of now.
Canadian ticker is running nice today..
Plus they are anticipating not having to do phase III.
The fda hasn't confirmed it yet but it seems likely.
So again... If they don't have to do phase III then whats next? Find a partner and go ahead with production?
So if they don't have to do phase 3 trials then whats next? Phase 3 is the last step before sales. Phase 4 is done during sales...
Thought the patent was issued.
Beat me to it. I think people got tired of all the wink wink nudge nudge crap. Kept spewing that crap and insisting we take him at his word without every providing any info.
Even a broken clock is right twice a day.
I have a co worker who is friends with the family and I met Oddi. If I can't get any info I doubt others can.
I've been pretty vocal on this board about the shortcomings of the company. But I'm here because of my own due diligence. I believe there is a lot of potential here. The snake oil salesman has no influence.
I stopped listening to that crap a while ago. From the cryptic messages here to pretending he isn't connected to ipci.ca.
Doog any word from your friend?
Doog said his friend was going and will give us an update